◀ Back to TP53
CCNG1 — TP53
Pathways - manually collected, often from reviews:
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
-
IRef Biogrid Interaction:
CCNG1
—
TP53
(physical association, affinity chromatography technology)
Zhao et al., Mol Cancer Res 2003*
-
IRef Biogrid Interaction:
CCNG1
—
TP53
(direct interaction, pull down)
Zhao et al., Mol Cancer Res 2003*
-
IRef Biogrid Interaction:
CCNG1
—
TP53
(physical association, affinity chromatography technology)
Ohtsuka et al., Oncogene 2003*
-
IRef Hprd Interaction:
TP53
—
CCNG1
(in vitro)
Zhao et al., Mol Cancer Res 2003*
-
IRef Hprd Interaction:
TP53
—
CCNG1
(in vivo)
Zhao et al., Mol Cancer Res 2003*
-
IRef Ophid Interaction:
CCNG1
—
TP53
(aggregation, interologs mapping)
Brown et al., Bioinformatics 2005
Text-mined interactions from Literome
Kato et al., Leukemia & lymphoma 1999
(Leukemia, Erythroblastic, Acute) :
In this process,
p53 recovered the wild-type p53 function and the expression of the p21 ( waf1/cip1/sdi1 ),
cyclin G1 and gadd45 genes was
increased
Verdoodt et al., Mutagenesis 1999
(Leukemia...) :
The results in KS, as compared with K562, confirm that wild-type
p53 can
prevent further
cycling of polyploid cells by blocking rereplication
Yoon et al., Exp Hematol 2001
:
The likelihood that suppression of bone marrow cellularity and cell
cycling is
mediated by
p53 was supported by the upregulation of p21, a cyclin dependent kinase inhibitor
Galmarini et al., Br J Cancer 2001
:
MN1 cells, but not MDD2 cells, displayed
wt-p53 protein accumulation as well as p21/WAF1 and
cyclin G1 induction after exposure to TBA
Kimura et al., Genes Cells 2002
:
Cyclin G1 associates with MDM2 and
regulates accumulation and degradation of
p53 protein
Jensen et al., Hepatology 2003
(Liver Neoplasms) :
Recent data show that
cyclin G1 can
regulate the levels of
p53 by a mechanism that involves dephosphorylation of Mdm2 by protein phosphatase 2A
Ohtsuka et al., Oncogene 2004
:
However,
cyclin G does not
cause similar reductions in
p53 levels in ATM mutated cells
Yew et al., Nature 1992
(Cell Transformation, Viral) :
These results indicate that
p53 probably
inhibits cell
cycling by functioning as a transcription factor
Tsuchihara et al., Cancer Res 2005
(Aneuploidy...) :
Ckap2 regulates aneuploidy, cell
cycling , and cell death in a
p53 dependent manner
Braithwaite et al., Virology 1990
:
Experiments with hydroxyurea show that
p53 activation does not
require continued cell
cycling and thus is likely to be a direct consequence of viral gene expression
Wang et al., Hepatology 2012
(Colorectal Neoplasms...) :
Using coimmunoprecipitation, a luciferase reporter system, and electrophoretic mobility shift assay, we further demonstrated that
cyclin G(1) specifically interacted with p53, and this interaction
blocked the specific binding of
p53 to HBV enhancer elements and simultaneously abrogated p53 mediated inhibition of HBV transcription
Apostolidis et al., Physiol Genomics 2012
:
In primary megakaryocytes and in the megakaryocytic cell line CHRF, loss or knock-down of
p53 enhances cell
cycling and inhibits apoptosis, leading to increased polyploidization
Colombel et al., Oncogene 1995
:
However, wild-type
p53 does appear to enhance this process, especially in the early period following castration, and this protein may
regulate an aberrant prostate cell
cycling activity that follows castration
Elias et al., Int J Dermatol 1995
(Psoriasis) :
Since PCNA is a marker of cellular proliferation and
p53 inhibits cellular
cycling , some of the beneficial effects of PTU and MMI in psoriasis may depend on the ability of the drugs to impair cellular turnover, perhaps by binding to the triiodothyronine ( T3 ) receptor
Bates et al., Oncogene 1996
:
Both human G-cyclins are induced by the DNA damaging agent actinomycin-D and although the induction of
cyclin G1 is clearly
p53 dependent , activation of cyclin G2 expression was observed in the absence of p53
Shimizu et al., Biochem Biophys Res Commun 1998
:
To investigate regulation mechanisms of G2/M phase transition, we studied the association of cell cycle progression with
p53 dependent p21/waf-1 and
cyclinG expression
Jensen et al., Hepatology 1998
:
The expression of
cyclin G1 is
induced by transforming growth factor beta1 and
p53 , as well as by multiple mitogenic stimuli in mammalian cells in culture